Gathering data on primary ovarian leiomyosarcoma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect and analyze comprehensive data on primary ovarian leiomyosarcoma (POLMS), a rare form of ovarian cancer. It will utilize both retrospective and prospective methodologies to gather historical cases diagnosed since 1980, alongside newly identified cases. Data will be standardized and centralized using an electronic Case Report Form (eCRF) on REDCap, focusing on patient demographics, clinical presentation, treatment modalities, and outcomes. The goal is to uncover patterns in diagnosis and treatment to establish evidence-based guidelines for managing this aggressive cancer.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of primary leiomyosarcoma of the ovary;
* Patients diagnosed with POLMS for whom data relating to diagnosis and treatment are available.
* Aged between 18 and 99 years

Exclusion Criteria:

\- All patients with other forms of ovarian sarcoma (rhabdomyosarcomas, fibrosarcomas, stromal cell sarcomas) and patients diagnosed with leiomyosarcoma of the uterus will be excluded.

Where it's running

• AOU Policlinico di Modena
  Modena, Italy, Italy Recruiting
• Azienda Ospedaliero Universitaria di Parma - S.C. Ostetricia e Ginecologia
  Parma, Pr, Italy Recruiting
• Azienda USL IRCCS di Reggio Emilia
  Reggio Emilia, Re, Italy Recruiting
• Malzoni - Avellino
  Avellino, Italy Recruiting
• Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" - Catania
  Catania, Italy Recruiting
• IRCCS Ospedale San Raffaele
  Milan, Italy Recruiting

Study contacts

• Study coordinator: Vincenzo Dario Mandato, MD
• Email: vincenzodario.mandato@ausl.re.it
• Phone: +39 0522 295467

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• KLF4 Epigenetic Modulation in Colorectal Tissue

  Researchers will look at how the KLF4 gene’s methylation changes as colorectal tissue moves from polyps to more advanced lesions to see if this reflects or relates to gene activity.

  Recruiting Azienda USL Reggio Emilia - IRCCS · Reggio Emilia · NCT07901335

• Lung Ultrasound Score to predict BPD in very preterm babies

  This study tests whether lung ultrasound scores in the first two weeks of life can predict which extremely preterm babies will develop bronchopulmonary dysplasia.

  Recruiting at 4 sites Azienda USL Reggio Emilia - IRCCS · Modena and 3 other locations · NCT07633184

• Hematologic cancer survivors after stem cell transplant try a personalized care plan

  This study tests a personalized Survivorship Care Plan for people with hematologic cancer who have undergone a stem cell transplant to see if it’s feasible within the Italian health system.

  Recruiting Azienda USL Reggio Emilia - IRCCS · Reggio Emilia · NCT07579065

• Comprehensive molecular and immune profiling for malignant pleural mesothelioma

  This project will test whether detailed molecular and immune profiling of tumors from adults with malignant pleural mesothelioma can find biomarkers to better guide immunotherapy.

  Recruiting at 4 sites Azienda USL Reggio Emilia - IRCCS · Catania and 3 other locations · NCT07561190

• Physical activity patterns in cancer survivors treated at the MOvement & REhabilitation clinic

  This project will follow adult cancer survivors attending the MOvement & REhabilitation clinic to see how their weekly physical activity levels change over time after personalized physiotherapy support.

  Recruiting Azienda USL Reggio Emilia - IRCCS · Reggio Emilia · NCT07373626

• Treatment and outcomes after mild head injury

  Researchers are looking at past emergency department records to see how often adults with mild head injury develop serious complications and whether the Canadian CT Head Rule or the NEXUS Head CT better predicts who will need surgery or die.

  Recruiting Azienda USL Reggio Emilia - IRCCS · Bologna and 3 other locations · NCT07339319

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.